GLENMARK PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
08 Jun 2021
Glenmark's interim data from PMS Study on Favipiravir (FabiFlu??) supports its safety and effectiveness in real world settings with no new safety signals or concerns in Covid-19<BR> patients
Source:
BSE India